Pfizer announced results from its Phase 3 study comparing combination therapy of Vfend (voriconazole; Pfizer) and Eraxis (anidulafungin; Pfizer) to Vfend monotherapy for the treatment of invasive aspergillosis (IA).
The FDA is informing the public that chronic therapy with high-doses of Diflucan (fluconazole; Pfizer) may be associated with a rare and distinct set of birth defects in infants whose mothers were treated in the first trimester of pregnancy.
The CDC has updated its treatment guidelines for sexually transmitted diseases.
Strativa has made available Oravig (miconazole buccal tablets) for the treatment of oropharyngeal candidiasis (OPC) in patients ≥16 years of age.
